These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 19451796)
1. High ongoing burden of cryptococcal disease in Africa despite antiretroviral roll out. Jarvis JN; Boulle A; Loyse A; Bicanic T; Rebe K; Williams A; Harrison TS; Meintjes G AIDS; 2009 Jun; 23(9):1182-3. PubMed ID: 19451796 [No Abstract] [Full Text] [Related]
2. Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100-200 cells/mm Wykowski J; Galagan SR; Govere S; Wallis CL; Moosa MY; Celum C; Drain PK BMC Infect Dis; 2020 Jan; 20(1):61. PubMed ID: 31959112 [TBL] [Abstract][Full Text] [Related]
3. Is HIV-associated tuberculosis a risk factor for the development of cryptococcal disease? Jarvis JN; Harrison TS; Corbett EL; Wood R; Lawn SD AIDS; 2010 Feb; 24(4):612-4. PubMed ID: 19952711 [TBL] [Abstract][Full Text] [Related]
4. Decreasing incidence of cryptococcal meningitis in West Africa in the era of highly active antiretroviral therapy. Bamba S; Lortholary O; Sawadogo A; Millogo A; Guiguemdé RT; Bretagne S AIDS; 2012 May; 26(8):1039-41. PubMed ID: 22552479 [TBL] [Abstract][Full Text] [Related]
5. Factors influencing cerebrospinal fluid and plasma HIV-1 RNA detection rate in patients with and without opportunistic neurological disease during the HAART era. Christo PP; Greco DB; Aleixo AW; Livramento JA BMC Infect Dis; 2007 Dec; 7():147. PubMed ID: 18096083 [TBL] [Abstract][Full Text] [Related]
6. Cryptococcal meningitis in HIV-infected patients: a longitudinal study in Cambodia. Espié E; Pinoges L; Balkan S; Chanchhaya N; Molfino L; Narom P; Pujades-Rodríguez M Trop Med Int Health; 2010 Nov; 15(11):1375-81. PubMed ID: 20868415 [TBL] [Abstract][Full Text] [Related]
7. Cryptococcal meningitis in a tertiary hospital in Pretoria, mortality and risk factors - A retrospective cohort study. Hiesgen J; Schutte C; Olorunju S; Retief J Int J STD AIDS; 2017 Apr; 28(5):480-485. PubMed ID: 27255493 [TBL] [Abstract][Full Text] [Related]
8. Utility of Cryptococcal Antigen Screening and Evolution of Asymptomatic Cryptococcal Antigenemia among HIV-Infected Women Starting Antiretroviral Therapy in Thailand. Kwan CK; Leelawiwat W; Intalapaporn P; Anekthananon T; Raengsakulrach B; Peters PJ; McNicholl JM; Park BJ; McConnell MS; Weidle PJ J Int Assoc Provid AIDS Care; 2014; 13(5):434-7. PubMed ID: 24003059 [TBL] [Abstract][Full Text] [Related]
9. Epidemiology of adult meningitis during antiretroviral therapy scale-up in southern Africa: Results from the Botswana national meningitis survey. Tenforde MW; Mokomane M; Leeme T; Tlhako N; Tsholo K; Ramodimoosi C; Dube B; Mokobela KO; Tawanana E; Chebani T; Pilatwe T; Hurt WJ; Mitchell HK; Molefi M; Mullan PC; Guthrie BL; Farquhar C; Steenhoff AP; Mine M; Jarvis JN J Infect; 2019 Sep; 79(3):212-219. PubMed ID: 31255634 [TBL] [Abstract][Full Text] [Related]
10. Outcomes of cryptococcal meningitis in antiretroviral naïve and experienced patients in South Africa. Jarvis JN; Meintjes G; Harrison TS J Infect; 2010 Jun; 60(6):496-8. PubMed ID: 20307571 [No Abstract] [Full Text] [Related]
11. Evaluation of screening and treatment of cryptococcal antigenaemia among HIV-infected persons in Soweto, South Africa. Govender NP; Roy M; Mendes JF; Zulu TG; Chiller TM; Karstaedt AS HIV Med; 2015 Sep; 16(8):468-76. PubMed ID: 25689352 [TBL] [Abstract][Full Text] [Related]
12. [Causes of death in patients with HIV infection in two Tunisian medical centers]. Chelli J; Bellazreg F; Aouem A; Hattab Z; Mesmia H; Lasfar NB; Hachfi W; Masmoudi T; Chakroun M; Letaief A Pan Afr Med J; 2016; 25():105. PubMed ID: 28292068 [TBL] [Abstract][Full Text] [Related]
13. Asymptomatic cryptococcal antigen prevalence detected by lateral flow assay in hospitalised HIV-infected patients in São Paulo, Brazil. Vidal JE; Toniolo C; Paulino A; Colombo A; Dos Anjos Martins M; da Silva Meira C; Pereira-Chioccola VL; Figueiredo-Mello C; Barros T; Duarte J; Fonseca F; Alves Cunha M; Mendes C; Ribero T; Dos Santos Lazera M; Rajasingham R; Boulware DR Trop Med Int Health; 2016 Dec; 21(12):1539-1544. PubMed ID: 27699970 [TBL] [Abstract][Full Text] [Related]
14. The burden of HIV-associated cryptococcal disease. Harrison TS AIDS; 2009 Feb; 23(4):531-2. PubMed ID: 19240459 [No Abstract] [Full Text] [Related]
15. Frequency of cryptococcal meningitis in HIV-1 infected patients in north central Nigeria. Gomerep SS; Idoko JA; Ladep NG; Ugoya SO; Obaseki D; Agbaji OA; Agaba P; Akanbi MO; Badung BP; Otitoloju O Niger J Med; 2010; 19(4):395-9. PubMed ID: 21526627 [TBL] [Abstract][Full Text] [Related]
16. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. Rajasingham R; Smith RM; Park BJ; Jarvis JN; Govender NP; Chiller TM; Denning DW; Loyse A; Boulware DR Lancet Infect Dis; 2017 Aug; 17(8):873-881. PubMed ID: 28483415 [TBL] [Abstract][Full Text] [Related]
17. Profile of central nervous system disease in HIV/AIDS patients with special reference to cryptococcal infections. Wadhwa A; Kaur R; Bhalla P Neurologist; 2008 Jul; 14(4):247-51. PubMed ID: 18617851 [TBL] [Abstract][Full Text] [Related]
18. Prevalence and factors associated with cryptococcal antigenemia among severely immunosuppressed HIV-infected adults in Uganda: a cross-sectional study. Oyella J; Meya D; Bajunirwe F; Kamya MR J Int AIDS Soc; 2012 Mar; 15(1):15. PubMed ID: 22417404 [TBL] [Abstract][Full Text] [Related]
19. Prevalence, correlates, and outcomes of cryptococcal antigen positivity among patients with AIDS, United States, 1986-2012. McKenney J; Bauman S; Neary B; Detels R; French A; Margolick J; Doherty B; Klausner JD Clin Infect Dis; 2015 Mar; 60(6):959-65. PubMed ID: 25422390 [TBL] [Abstract][Full Text] [Related]
20. Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: an international observational study. Mussini C; Pezzotti P; Miró JM; Martinez E; de Quiros JC; Cinque P; Borghi V; Bedini A; Domingo P; Cahn P; Bossi P; de Luca A; d'Arminio Monforte A; Nelson M; Nwokolo N; Helou S; Negroni R; Jacchetti G; Antinori S; Lazzarin A; Cossarizza A; Esposito R; Antinori A; Aberg JA; Clin Infect Dis; 2004 Feb; 38(4):565-71. PubMed ID: 14765351 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]